基于小鼠模型筛选黄芪当归治疗2型糖尿病的最佳配比及最优半仿生提取工艺

中国医药导刊 ›› 2021, Vol. 23 ›› Issue (11): 828-834.

基于小鼠模型筛选黄芪当归治疗2型糖尿病的最佳配比及最优半仿生提取工艺

冉建新1，许蕊蕊2，王晓杰3*

1.北京市第六医院，北京100007； 2.北京中医药大学，北京 102488； 3.北京电子科技职业学院，北京 100176

收稿日期:2021-04-21 修回日期:2021-11-19 出版日期:2021-11-28 发布日期:2021-11-28
基金资助:
“北京市高层次创业人才支持计划领军人才”项目[项目编号：PXM2018-014306-000035；项目名称：教师队伍建设—高创计划教学名师（市级）

Screening of the Optimal Ratio of Astragalus-Angelica and the Optimal Semi-Bionic Extraction Process for Treating Type 2 Diabetic in Mice Model

1. Beijing Sixth Hospital, Beijing 100007,China; 2. Beijing University of Chinese Medicine, Beijing 102488,China; 3. School of Pharmacy, Shenyang Medical College, Liaoning Shenyang 100176,China

Received:2021-04-21 Revised:2021-11-19 Online:2021-11-28 Published:2021-11-28
Contact: wang xiaojie E-mail:wxj0045@126.com

摘要/Abstract

摘要： 目的：寻找黄芪、当归治疗2型糖尿病小鼠的最佳配比及最优半仿生提取工艺。方法：以2型糖尿病小鼠血糖值、进食量和体重为指标，通过口服灌胃不同比例黄芪当归的水煎液，筛选出当归、黄芪治疗2型糖尿病小鼠的最佳配比；运用中心组合设计实验，以2型糖尿病小鼠第14天和第0天的血糖差值、进食量差值、和体重差值为指标，优化当归、黄芪半仿生提取的最佳工艺条件。结果：当归、黄芪治疗2型糖尿病小鼠的最佳配比是黄芪∶当归为7∶2；半仿生提取当归、黄芪的最佳工艺条件为第1次提取人工胃液用量为7.7倍，第1次提取时间为2.6 h，第2次提取人工肠液用量为6.2倍，第2次提取时间为3.5 h。结论：本实验确定了当归、黄芪治疗2型糖尿病小鼠的最佳配比及半仿生提取的最佳工艺条件，为临床上使用当归、黄芪治疗2型糖尿病提供了一定依据。

关键词: font-size:medium, ">当归；黄芪；半仿生提取；2型糖尿病

Abstract: Objective： To explore the optimal ratio and the optimal semi-bionic extraction process for astragalus and angelica treating type 2 diabetic mice. Methods： Taking the blood glucose level, food intake and body weight of mice with type II diabetic as indicators, the optimal ratio of astragalus and angelica in the treatment of type 2 diabetes was selected by orally gavage with different proportions of astragalus and angelica decoction. Utilizing the central combination design experiments to optimize the process of semi-bionic extraction of astragalus and angelica with the differences in blood sugar lowering, food intake, and body weight on the 14th day and the 0th day of treatment in type II diabetic mice.Results： The optimal proportion of astragalus and angelica in the treatment of type II diabetic mice was 7∶2. The optimal process for semi-bionic extraction of angelica and astragalus were that the amount of artificial gastric juice for the first time extraction was 7.7 times, extraction duration was 2.6 h, and the amount of artificial intestinal fluid used for the second extraction was 6.2 times, and the second extraction duration was 3.5 h.Conclusion： The results of this experiment provide a basis for the clinical use of angelica and astragalus in the treatment of type II diabetes.

Key words: Angelica, Astragalus, Semi-bionic extraction, Type 2 diabetes

中图分类号:

冉建新, 许蕊蕊, 王晓杰. 基于小鼠模型筛选黄芪当归治疗2型糖尿病的最佳配比及最优半仿生提取工艺[J]. 中国医药导刊, 2021, 23(11): 828-834.

RAN Jianxin , XU Ruirui , WANG Xiaojie . Screening of the Optimal Ratio of Astragalus-Angelica and the Optimal Semi-Bionic Extraction Process for Treating Type 2 Diabetic in Mice Model[J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2021, 23(11): 828-834.

参考文献

[1]贾惠玲.基于数据挖掘的马鸿杰主任医师治疗糖尿病肾脏病的用药规律研究[M].天津中医药大学,2020：5.
[2]董又滋,赵泉霖,高丽君,等.黄芪-当归药对治疗糖尿病心肌病的分子机制[J].中国实验方剂学杂志. 2021,27(18):16-24.
     [3]王单单,郭丽娜,裴媛,等.黄芪-当归治疗糖尿病肾病作用机制的网络药理学研究[J].中药新药与临床药理，2020,31(5):566-575.
     [4]王语聪,谢智鑫,张学艳,等.黄芪对2型糖尿病大鼠碱性磷酸酶与炎症反应的影响[J].食品工业科技,2021,42(13):351-357.
     [5]董文南,李克招,张文婷,等.多糖降血糖作用及其机制研究进展[J].中国实验方剂学杂志,2019,25(19):219-225.
     [6]蒋亚丽,王辉.当归药性与功用考证[J].中医药导报,2019,25(11):72-74,77.
     [7]尚伟庆.黄芪当归合剂对肾病综合征患者肾功能、炎症机制及疗效的影响[J].中华中医药学刊,2017,35(5):1339-1341.
     [8]聂娟,谢丽华,马港圆,等.中药黄芪的化学成分及药理作用研究进展[J].湖南中医杂志,2018,34(7):228-231.
     [9]陈琳,朱靖,王嵩,等.当归主要活性成分提取方法及其活性研究进展[J].上海医药,2021,42(9):71-75.
     [10]韩晓冰,贾冉,张鼎,等.苯那普利与黄芪当归合剂治疗糖尿病肾病临床观察[J].全科口腔医学电子杂志,2019,6(25):163.
     [11]王秋红,赵珊,王鹏程,等.半仿生提取法在中药提取中的应用[J].中国实验方剂学杂志,2016,22(18):187-191.
     [12]He GD,Yin YG,Yan XX,et al.Semi-bionic extraction of effective ingredient from fishbone by high intensity pulsed electric fields[J].Journal of Food Process Engineering,2017,40(2):1-9.
     [13]国家药典委员会.中华人民共和国药典（一部）［S］. 北京：中国医药科技出版社，2015：302.
     [14]石莹莹.半仿生-生物酶提取法在中草药中的应用[J].河南化工,2020,37(3):10-13.
     [15]吴国泰,景琪,刘五州,等.当归黄芪半仿生提取物对腹部术后大鼠胃肠运动功能障碍的影响[J].中国现代应用药学,2016,33(5):533-539.
     [16]刘五州,妥海燕,吴国泰,等.当归补血汤半仿生提取工艺研究[J].中药药理与临床,2015,31(5):19-22,152.
     [17]陈自泓,黄可儿.多指标正交设计优化黄芪半仿生提取工艺的研究[J].广州中医药大学学报,2019,36(11):1820-1826.
     [18]Liu WZ,Tuo HY,Wu GT,et al.Semi bionic extraction of Dangguibuxuetang[J].Pharmacol Clin Chin Mater Med,2015,31(5):19-23.
     [19]朱启源. 两种海参多糖组分的制备及其改善大鼠2型糖尿病作用研究[D].华南理工大学,2020.
     [20]侯赛红,孙树芹,徐万群,等.黄芪多糖对糖尿病心肌病大鼠心肌细胞凋亡的影响[J].青岛大学学报(医学版). 2020,56(3):293-296.
     [21]汤卓红.当归多糖对2型糖尿病小鼠肝脏和胰岛损伤的保护作用及机制研究[D].华中科技大学,2018.
     [22]任钧国,刘建勋.中药复方新药组方设计思路与方法[J].中国中药杂志,2015,40(17):3413-3415.

快速检索引用检索图表检索高级检索